Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-12 Sale |
2020-11-13 5:13 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
30,000 | $70.05 | $2,101,590 | 274,998 (Indirect Direct) |
View |
| 2020-11-10 Sale |
2020-11-12 4:21 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
10,000 | $60.03 | $600,310 | 304,998 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 5:53 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
10,000 | $50.18 | $501,830 | 314,998 (Indirect Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 6:45 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $40.74 | $2,155,603 | 342,132 (Indirect Direct) |
View |
| 2020-09-10 Sale |
2020-09-14 9:38 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
3,689 | $31 | $114,359 | 190,141 (Indirect) |
View |
| 2020-08-12 Sale |
2020-08-14 4:50 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
1,443,247 | $31.65 | $45,678,768 | 12,649,669 (Indirect) |
View |
| 2020-06-26 Sale |
2020-06-30 7:17 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
250,000 | $23.97 | $5,993,052 | 14,092,916 (Indirect) |
View |
| 2020-06-19 Sale |
2020-06-23 5:41 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
255,000 | $24.72 | $6,304,373 | 14,342,916 (Indirect) |
View |
| 2020-06-16 Sale |
2020-06-18 9:41 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
400,000 | $26.1 | $10,440,000 | 2,739,043 (Direct) |
View |
| 2020-06-05 Sale |
2020-06-09 4:10 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
1,922,855 | $25.75 | $49,513,516 | 14,597,916 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-08 Exercise |
2020-10-13 6:45 pm |
N/A 2026-07-01 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $0 | 342,132 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 6:45 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $5.28 | 342,132 (Indirect) |
View |
Ownership |
2020-09-28 4:30 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BIOGEN INC. Biogen MA Inc. 10% Owner |
0 | $0 | 13,310,243 (Indirect) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:38 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
5,643 | $0 | 158,320 (Direct) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:38 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,954 | $32.88 | 158,320 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
5,643 | $0 | 622,468 (Direct) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
1,954 | $32.88 | 622,468 (Indirect) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,954 | $32.87 | 1,010,177 (Indirect) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
5,643 | $0 | 1,010,177 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:20 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:19 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:17 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:14 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-18 Gift |
2020-06-18 9:42 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
40,000 | $0 | 2,411,317 (Indirect) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:03 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:02 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:02 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:01 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | Klein Peter S Director |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:00 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:00 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 5:59 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 5:58 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director |
18,436 | $0 | 18,436 (Direct) |
View |